Your browser doesn't support javascript.
loading
Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model.
Latenstein, Anouk E J; van Roessel, Stijn; van der Geest, Lydia G M; Bonsing, Bert A; Dejong, Cornelis H C; Groot Koerkamp, Bas; de Hingh, Ignace H J T; Homs, Marjolein Y V; Klaase, Joost M; Lemmens, Valery; Molenaar, I Quintus; Steyerberg, Ewout W; Stommel, Martijn W J; Busch, Olivier R; van Eijck, Casper H J; van Laarhoven, Hanneke W M; Wilmink, Johanna W; Besselink, Marc G.
Afiliação
  • Latenstein AEJ; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • van Roessel S; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • van der Geest LGM; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Bonsing BA; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
  • Dejong CHC; Department of Surgery, Maastricht University Medical Centre and NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht, The Netherlands.
  • Groot Koerkamp B; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • de Hingh IHJT; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.
  • Homs MYV; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Klaase JM; Department of Surgery, University Medical Center Groningen, Groningen, The Netherlands.
  • Lemmens V; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.
  • Molenaar IQ; Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Steyerberg EW; Department of Surgery, Regional Academic Cancer Center Utrecht, St Antonius Hospital Nieuwegein and University Medical Center Utrecht Cancer Center, Utrecht, The Netherlands.
  • Stommel MWJ; Department of Public Health, Erasmus MC, Rotterdam, The Netherlands.
  • Busch OR; Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van Eijck CHJ; Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • van Laarhoven HWM; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Wilmink JW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Besselink MG; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Ann Surg Oncol ; 27(7): 2516-2524, 2020 Jul.
Article em En | MEDLINE | ID: mdl-32052299
BACKGROUND: Conditional survival is the survival probability after already surviving a predefined time period. This may be informative during follow-up, especially when adjusted for tumor characteristics. Such prediction models for patients with resected pancreatic cancer are lacking and therefore conditional survival was assessed and a nomogram predicting 5-year survival at a predefined period after resection of pancreatic cancer was developed. METHODS: This population-based study included patients with resected pancreatic ductal adenocarcinoma from the Netherlands Cancer Registry (2005-2016). Conditional survival was calculated as the median, and the probability of surviving up to 8 years in patients who already survived 0-5 years after resection was calculated using the Kaplan-Meier method. A prediction model was constructed. RESULTS: Overall, 3082 patients were included, with a median age of 67 years. Median overall survival was 18 months (95% confidence interval 17-18 months), with a 5-year survival of 15%. The 1-year conditional survival (i.e. probability of surviving the next year) increased from 55 to 74 to 86% at 1, 3, and 5 years after surgery, respectively, while the median overall survival increased from 15 to 40 to 64 months at 1, 3, and 5 years after surgery, respectively. The prediction model demonstrated that the probability of achieving 5-year survival at 1 year after surgery varied from 1 to 58% depending on patient and tumor characteristics. CONCLUSIONS: This population-based study showed that 1-year conditional survival was 55% 1 year after resection and 74% 3 years after resection in patients with pancreatic cancer. The prediction model is available via www.pancreascalculator.com to inform patients and caregivers.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article